Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hiddemann

Showing results (121-130 of 533) with videos related to

Pageof 54
Sort By:
Der Internist|November 2, 2004
[Monoclonal antibody treatment of malignant lymphoma]C Buske, M Dreyling, M Unterhalt, et al.
Der Internist|July 14, 2001
[Clinical use of monoclonal antibodies in malignant lymphomas]R Schnell, W Hiddemann, V Diehl, et al.
Cancer|June 1, 1986
DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypesW Hiddemann, B Wörmann, W Göhde, et al.
Blood|November 15, 1995
Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysisM Kneba, I Bolz, B Linke, et al.
Biological Chemistry Hoppe-Seyler|May 1, 1995
Improvement of hammerhead ribozymes cleaving mdr-1 mRNAK Palfner, M Kneba, W Hiddemann, et al.
Anti-Cancer Drugs|November 1, 1996
Increase of P-glycoprotein-mediated drug resistance by hsp 90 betaJ Bertram, K Palfner, W Hiddemann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine]T Büchner, D Kamanabroo, W Hiddemann, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxRJ Bertram, K Palfner, W Hiddemann, et al.
Blood|August 26, 1998
Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donorsS Schnittger, B Wörmann, W Hiddemann, et al.
Annals of Hematology|May 6, 2004
Novel treatment strategies in follicular lymphomaC Buske, H Dreyling, M Unterhalt, et al.
Pageof 54

Showing results (121-130 of 533) with videos related to

Sort By:
Pageof 54
Der Internist|November 2, 2004
[Monoclonal antibody treatment of malignant lymphoma]C Buske, M Dreyling, M Unterhalt, et al.
Der Internist|July 14, 2001
[Clinical use of monoclonal antibodies in malignant lymphomas]R Schnell, W Hiddemann, V Diehl, et al.
Cancer|June 1, 1986
DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypesW Hiddemann, B Wörmann, W Göhde, et al.
Blood|November 15, 1995
Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysisM Kneba, I Bolz, B Linke, et al.
Biological Chemistry Hoppe-Seyler|May 1, 1995
Improvement of hammerhead ribozymes cleaving mdr-1 mRNAK Palfner, M Kneba, W Hiddemann, et al.
Anti-Cancer Drugs|November 1, 1996
Increase of P-glycoprotein-mediated drug resistance by hsp 90 betaJ Bertram, K Palfner, W Hiddemann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine]T Büchner, D Kamanabroo, W Hiddemann, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxRJ Bertram, K Palfner, W Hiddemann, et al.
Blood|August 26, 1998
Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donorsS Schnittger, B Wörmann, W Hiddemann, et al.
Annals of Hematology|May 6, 2004
Novel treatment strategies in follicular lymphomaC Buske, H Dreyling, M Unterhalt, et al.
Pageof 54